| Filename | 2023-CMTA-Annual-Report-1.pdf |
| Filesize | 17.83 MB |
| Version | 1 |
| Date added | September 3, 2024 |
| Downloaded | 582 times |
| Category | Annual Report/Financials |
| stackable_optimized_css_raw | a:0:{} |
The Charcot-Marie-Tooth Association’s 2023 Annual Report highlights a year of remarkable growth, generosity, and impact bolstered by a new CEO. With over $6 million in revenue, 90% of funds directly supported CMTA’s mission, earning a perfect 100% rating from Charity Navigator for the fourth consecutive year. CMTA’s Strategy To Accelerate Research (STAR) program invested nearly $4.3 million across 50 active research projects, accelerating genetic therapies, small molecule treatments, and repurposing already FDA-approved drugs. Community outreach expanded significantly, with the COMPASS program growing by 140% and Camp Footprint seeing a 23% growth in participation. CMTA’s Centers of Excellence network grew to 55 locations, supporting 9,000 patient visits. The report underscores the CMTA’s unwavering commitment to accelerating research, empowering patients, improving the quality of life for those with CMT, and working towards a cure.